Top insider trades (week of June 8)

How CEO Watcher Works

Happy Saturday!

Welcome to this week’s edition of CEO Watcher.

This is the only tool that tracks the returns of insiders so we know which insider trades are worth copying.

This week we found:

• $DERM is up 45% since we found it

• Insider at $BHVN with 81% 1y returns buys the stock

• and more…

Have a great weekend and thanks for reading!

Connor

💰 Previous Winner

$DERM was the top purchase highlighted in the March 26th CEO Watcher Premium (20% discount with that link) email when the CEO bought the stock after the price dipped. The stock opened at $3.23 on March 26 after the email was sent and has since popped over 40% two different times and is currently up 45%.

Upgrade to CEO Watcher Premium (20% off with this link) to get all of the top insider trades as soon as they happen instead of just receiving 3 on the weekend.

👀 Top Insider Trades this Week

🥇Director at Biohaven Ltd. ($BHVN)

The Director purchased 28,000 shares at $35.58/share ($996K total) which increased their vested holdings by 0.4%. The current price is $34.00 (-4.4%). Their median purchase size is $1.00M and this is their 11th largest purchase out of 18 all time. (trade link)

Historic Returns
1m returns: 15% weighted | 6% median | 62% win rate (10/16)
3m returns: 35% weighted | 21% median | 93% win rate (14/15)
6m returns: 20% weighted | 34% median | 80% win rate (12/15)
1y returns: 94% weighted | 81% median | 100% win rate (10/10)

🥈 Director at Serina Therapeutics, Inc. ($SER)

The Director purchased 6,378 shares at $9.50/share ($60,591.00 total) which increased their vested holdings by 46.1%. The current price is $10.00 (+5.2%). Their median purchase size is $402K and this is their 10th largest purchase out of 13 all time. (trade link)

Historic Returns
1m returns: 5% weighted | 11% median | 71% win rate (5/7)
3m returns: 32% weighted | 38% median | 100% win rate (4/4)
6m returns: 35% weighted | 35% median | 100% win rate (4/4)
1y returns: 66% weighted | 71% median | 100% win rate (3/3)

🥉 Chief Financial Officer at Perspective Therapeutics, Inc. ($CATX)

The Chief Financial Officer purchased 25,006 shares at $1.40/share ($35,007.15 total) which increased their vested holdings by 7.9%. The current price is $1.20 (-14.2%). Their median purchase size is $32,501.40 and this is their 1st largest purchase out of 5 all time. (trade link)

Historic Returns
1m returns: 10% weighted | 0% median | 50% win rate (2/4)
3m returns: 195% weighted | 103% median | 100% win rate (4/4)
6m returns: 91% weighted | 60% median | 100% win rate (3/3)
1y returns: 27% weighted | 56% median | 67% win rate (2/3)

Note: 1 other insider also purchased the stock

Get the insider trades as soon as they happen

By upgrading to CEO Watcher Premium, you get the top insider trades as soon as they happen.

Each morning you get an email with the best insider buys and sells.

CEO Watcher Premium perks:

• The daily CEO Watcher Premium email (sent before market open on days the market is open) with the top insider buys/sells

• The top insider buys and sells each day (ranked by the proprietary CEO Watcher ranking system)

• The biggest insider buys and sells each day (by trade size and by how much it increases/decreases the insider's holdings

Just one profitable trade will pay for a full year (or more) of CEO Watcher Premium. And, I’ll even make a deal with you. If you upgrade to CEO Watcher Premium and don’t get 10x more value than what you paid, I’ll give you your money back at any time with no questions asked.